Ischemic cholangiopathy after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 4, 2005, Pages 495-501

  Cameron, Andrew M ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biliary strictures; Ischemic cholangiopathy; Non anastomotic strictures; Non heart beating donor; Orthotopic liver transplantation

Indexed keywords

1 ETHYL 2 [N (2 METHOXYBENZOYL) N [2 METHOXY 3 [4 (OCTADECYLCARBAMOYLOXY)PIPERIDINOCARBONYLOXY]PROPOXYCARBONYL]AMINOMETHYL]PYRIDINIUM CHLORIDE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; GLUCONIC ACID; HTK SOLUTION; LIVER ENZYME; PENTOXIFYLLINE; PROSTAGLANDIN E1; TACROLIMUS; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNIVERSITY OF WISCONSIN SOLUTION;

BILE DUCT INJURY; BILE DUCT OBSTRUCTION; GRAFT SURVIVAL; HUMAN; ISCHEMIA; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PREOPERATIVE CARE; REPERFUSION INJURY; REVIEW;

ANIMALS; BILE DUCT DISEASES; BIOPSY, NEEDLE; HUMANS; LIVER TRANSPLANTATION; MODELS, ANIMAL;

EID: 28444439619     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Greif F, Bronsther OL, Van Thiel DH, Casavilla A, Iwatsuki S, Tzakis A, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994;219:40-45.
2. Rabkin JM, Orloff SL, Reed MH, Wheeler LJ, Corless CL, Benner KG, et al. Biliary tract complications of side-to-side without T tube versus end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients. Transplantation 1998;65:193-199.
3. Colonna JO, Shaked A, Gomes AS, Colquhoun SD, Jurim O, McDiarmid SV, et al. Biliary strictures complicating liver transplantation. Ann Surg 1992;216:344-352.
4. Zajko AB, Campbell WL, Logsdon GA, Bron KM, Tzakis A, Esquivel CO, et al. Cholagiographic findings in hepatic artery occlusion after liver transplantation. AJR 1987;149:485-489.
5. Sanchez-Urdazpal L, Batts KP, Gores GJ, Moore SB, Sterioff S, Wiesner RH, et al. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg 1993; 218:152-158.
6. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16:49-53.
7. Evans RA, Raby ND, O'Grady JG, Karam JB, Nunnerley HB, Calne RY, et al. Biliary Complications following orthotopic liver transplantation. Clin Radiol 1990;41:190-194.
8. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Amer J kad 1993;161:297-300.
9. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, et al. Diagnostic features and clinical outcome of Ischemic-type biliary complications after liver transplantation. Hepatology 1993;17:605-609.
10. Ludwig J, Batts KP, MacCarty RL. Ischemic cholangitis in hepatic allografts. Mayo Clinic Proc 1992;67:519-526.
11. Batts KP. Ischemic Cholangitis. Mayo Clin Proc 1998;73: 380-385.
12. Aht P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver Transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003;75:1659-1663.
13. Northover J, Terblanche J. Bile duct blood supply: Its importance in human liver transplantation. Transplantation 1978; 26:67-69.
14. Northover JM, Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979;66:379-384.
15. Terblanche J, Allison HF, Northover JMA. An ischemic basis for biliary strictures. Surgery 1983;94:52-57.
16. Calne RY. The present status of liver transplantation. Transpl Proc 1977;9:209-216.
17. Li S, Stratta RJ, Langnas AN, Wood RP, Marujo W, Shaw BW. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992;164:536-540.
18. Guichelaar MMJ, Benson JT, Malinchoc M, Krom RAF, Wiesner RW, Charlton MR. Risk Factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transpl 2003;3:885-890.
19. Schon MR, Kollmar O, Wolf S, Schrem H, Matthes M, Akkoc N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001; 233:114.
20. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995;59: 197.
21. D'Alessandro AM, Hoffman RM, Knechtle SJ, Odorico JS, Becker YT, Musat A, et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000;128:579-588.
22. Reich DJ, Munoz SJ, Rothstein KD, Nathan HM, Edwards JM, Hasz RD, et al. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation 2000;70:1159-1166.
23. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004;239:87-92.
24. D'Alessandro AM, Fernandez LA, Chin LT, Shames BD, Turgeon NA, Scott DL, et al. Donation after cardiac death: the University of Wisconsin experience. Ann Transpl 2004;9: 68-71.
25. Sankary HN, McChesney L, Frye E, Cohn S, Foster P, Williams J. A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation. Hepatology 1995;21:63-69.
26. Cutrin JC, Cantino D, Biasi F, Chiarpotto E, Salizzoni M, Andorno E, et al. Reperfusion Damage to the bile canaliculi in transplanted human liver. Hepatology 1996;24:1053-1057.
27. Benkoel L, Dodero F, Hardwigsen J, Campan P, Botta-Fridlund D, Lombardo D, et al. Effect of ischemia-reperfusion on bile canalicular F-actin microfilaments in hepatocytes of human liver allograft. Dig Dis Sci 2001;46:1663-1667.
28. Garcia-Valdecasas Salgado JC. Non beating heart donors as a possible source for liver transplantation. Acta Chir Belg 2000; 100:268-271.
29. Valero R, Garcia-Valdecasas JC, Net M, Beltran J, Ordi J, Gonzalez FX, et al. L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart-beating donor pigs. Transplantation 2000;70:730-737.
30. Pannen BH, Al-Adih F, Bauer M, Clemens MG, Geiger KK. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 1998;27:755-764.
31. Kobayashi H, Nonami T, Kurokawa T, Takeuchi Y, Harada A, Nakao A, et al. Role of endogenous nitric oxide in ischemia reperfusion injury in rat liver. J Surg Res 1995;59:772-779.
32. Kupiec-Weglinski JW, Busuttil RW. Ischemia and Reperfusion injury in liver transplantation. Transpl Proc 2005;37: 1653-1656.
33. Takei Y, Marzi I, Gao W, Gores GJ, Lemasters JJ, Thurman RG. Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat. Transplantation 1991;51:959-965.
34. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Path 1994; 145:1421-1431.
35. He XS, Ma Y, Ju WQ, Wu LW, Wu JL, Liang YJ, et al. Dynamic microcirculatory changes in liver graft from non-heart-beating donor with warm ischemia in rat. Hepatobiliary Pancreat Dis Int 2004;3:179-182.
36. Net M, Valero R, Almenara R, Rull R, Gonzalez FJ, Taura P, et al. Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation 2001;71:1232-1237.
37. Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Transplantation 1993;56:495-500.
38. Yagi T, Sadamori H, Nakagawa H, Ishikawa T, Sasaki H, Ohta K, et al. Hepatic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. Transpl Proc 1997;29: 1390-1393.
39. Miyagi S, Ohkohchi N, Oikawa K, Satoh M, Tsukamoto S, Satomi S. Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft. Transplantation 2004;77: 1487-1493.
40. Takada Y, Taniguchi H, Fukunaga K, Yuzawa K, Otsuka M, Todoroki T, et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. Surgery 1998;126:692-698.
41. Berrevoet F, Schafer T, Vollmar B, Menger MD. Ischemic preconditioning: enough evidence to support clinical application in liver surgery and transplantation? Acta Chir Belg 2003; 103:485-489.
42. Azoulay D, Del Gaudio M, Andreani P, Andreani P, Ichai P, Sebag M, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function. Ann Surg 2005;242:133-139.
43. Tojimbara T, Wicomb WN, Garcia-Kennedy R, Bums W, Hayashi, M, Collins G, et al. Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function. Liver Transpl & Surg 1997;3:39-45.
44. Uchiyama M, Kozaki K, Nemoto T, Degawa H, Matsuno, N, Kubota K, et al. Liver transplantation from non-heart-beating donors: effect of machine perfusion preservation and pentoxyfylline. Transpl Proc 1998;30:3798-3800.
45. Garcia-Valdecasas JC, Tabet J, Valero R, Deulofeu. R, Taura P, Rull R, et al. Evaluation of ischemic injury during liver procurement from non-heart-beating donors. Eur Surg Res 1999;31:447-456.